B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference39 articles.
1. World cancer report 2014;Stewart,2014
2. Cancer statistics;Jemal;CA Cancer J Clin,2008
3. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease;Katz;J Am Coll Surg,2008
4. Systemic and adjuvant therapy for patients with pancreatic carcinoma;Clark;Cancer,1996
5. Costimulatory and coinhibitory receptors in anti-tumor immunity;Driessens;Immunol Rev,2009
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC);Cancer Pathogenesis and Therapy;2024-07
2. Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors;Exploration of Targeted Anti-tumor Therapy;2024-05-21
3. Advancements in Pancreatic Cancer Detection: Integrating Biomarkers, Imaging Technologies, and Machine Learning for Early Diagnosis;Cureus;2024-03-20
4. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance;Modern Pathology;2024-01
5. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition;BMC Cancer;2022-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3